Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pacher

Showing results (111-120 of 1,016) with videos related to

Pageof 102
Sort By:
The Journal of Physiology|December 19, 2000
Quantification of calcium signal transmission from sarco-endoplasmic reticulum to the mitochondriaP Pacher, P Csordás, T Schneider, et al.
The American Journal of Pathology|April 20, 2025
An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and BeyondLihong Fu, Burhan Yokus, Bin Gao, et al.
International Journal of Molecular Medicine|June 1, 2013
Role of poly(ADP-ribosyl)ation in a 'two-hit' model of hypoxia and oxidative stress in human A549 epithelial cells in vitroKatalin Erdélyi, Pál Pacher, László Virág, et al.
ACS Chemical Neuroscience|July 18, 2024
Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?Lauren M Park, Pal Pacher, Falk W Lohoff
ACS Chemical Neuroscience|July 9, 2026
PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic StrokeCarolina Vela, Josephin Wagner, Pal Pacher, et al.
Phytochemistry|August 29, 2001
Stress induced carbazole phytoalexins in Glycosmis speciesT Pacher, M Bacher, O Hofer, et al.
Stroke|September 2, 1999
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel openerZ Ungvari, P Pacher, V Kecskeméti, et al.
Expert Opinion on Investigational Drugs|April 5, 2011
Investigational A₃ adenosine receptor targeting agentsBalázs Koscsó, Balázs Csóka, Pál Pacher, et al.
Current Medicinal Chemistry|February 15, 2001
Current trends in the development of new antidepressantsP Pacher, E Kohegyi, V Kecskemeti, et al.
British Journal of Pharmacology|June 17, 2015
Role of the endocannabinoid system in diabetes and diabetic complicationsG Gruden, F Barutta, G Kunos, et al.
Pageof 102

Showing results (111-120 of 1,016) with videos related to

Sort By:
Pageof 102
The Journal of Physiology|December 19, 2000
Quantification of calcium signal transmission from sarco-endoplasmic reticulum to the mitochondriaP Pacher, P Csordás, T Schneider, et al.
The American Journal of Pathology|April 20, 2025
An Update on IL-22 Therapies in Alcohol-Associated Liver Disease and BeyondLihong Fu, Burhan Yokus, Bin Gao, et al.
International Journal of Molecular Medicine|June 1, 2013
Role of poly(ADP-ribosyl)ation in a 'two-hit' model of hypoxia and oxidative stress in human A549 epithelial cells in vitroKatalin Erdélyi, Pál Pacher, László Virág, et al.
ACS Chemical Neuroscience|July 18, 2024
Targeting Oxidative Stress in Neurodegenerative Disorders: A Novel Role for PCSK9 Inhibition?Lauren M Park, Pal Pacher, Falk W Lohoff
ACS Chemical Neuroscience|July 9, 2026
PCSK9 as an Emerging Target for Cerebrovascular Dysfunction and Neuroinflammation in Ischemic StrokeCarolina Vela, Josephin Wagner, Pal Pacher, et al.
Phytochemistry|August 29, 2001
Stress induced carbazole phytoalexins in Glycosmis speciesT Pacher, M Bacher, O Hofer, et al.
Stroke|September 2, 1999
Fluoxetine dilates isolated small cerebral arteries of rats and attenuates constrictions to serotonin, norepinephrine, and a voltage-dependent Ca(2+) channel openerZ Ungvari, P Pacher, V Kecskeméti, et al.
Expert Opinion on Investigational Drugs|April 5, 2011
Investigational A₃ adenosine receptor targeting agentsBalázs Koscsó, Balázs Csóka, Pál Pacher, et al.
Current Medicinal Chemistry|February 15, 2001
Current trends in the development of new antidepressantsP Pacher, E Kohegyi, V Kecskemeti, et al.
British Journal of Pharmacology|June 17, 2015
Role of the endocannabinoid system in diabetes and diabetic complicationsG Gruden, F Barutta, G Kunos, et al.
Pageof 102